Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements - Contingent Value Right and Common Stock Warrant Valuation (Detail)

v3.23.2
Fair Value Measurements - Contingent Value Right and Common Stock Warrant Valuation (Detail)
3 Months Ended 6 Months Ended
Jun. 16, 2023
USD ($)
item
$ / shares
shares
Jun. 30, 2023
USD ($)
Jun. 30, 2023
USD ($)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Change in valuation of contingent value right   $ (303,000) $ (303,000)
CVR Agreement      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Number of components | item 2    
Remaining value convertible $ 3,000,000.0    
Expected value of conversion right if rights are not converted into shares 0    
Fair value of conversion right 3,300,000 2,900,000 2,900,000
Fair value of contingent value liability $ 1,900,000 1,900,000 $ 1,900,000
Change in valuation of contingent value right   $ 300,000  
Warrants to purchase shares of common stock | shares 5,103,343    
Exercise price of warrant | $ / shares $ 0.3919    
Warrants term 10 years    
Issuance of warrants $ 2,300,000